Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0M1YV
|
||||
Former ID |
DNC007377
|
||||
Drug Name |
ELAEOCARPENINE
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530705] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H19NO2
|
||||
Canonical SMILES |
CC1=C(C(=CC=C1)O)C(=O)C2=CCCN3C2CCC3
|
||||
InChI |
1S/C16H19NO2/c1-11-5-2-8-14(18)15(11)16(19)12-6-3-9-17-10-4-7-13(12)17/h2,5-6,8,13,18H,3-4,7,9-10H2,1H3/t13-/m1/s1
|
||||
InChIKey |
KNSLYJICIDVPEX-CYBMUJFWSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [530705] | |
Delta-type opioid receptor | Target Info | Inhibitor | [530705] | ||
Kappa-type opioid receptor | Target Info | Inhibitor | [530705] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Opioid prodynorphin pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.